Xi'An Jinhua Enterprise Group

Xi'an Jinhua Enterprise Group is a diversified Chinese conglomerate with a primary focus on the pharmaceutical and healthcare sectors. Its core subsidiary, Xi'an Jinhua Pharmaceutical, is a publicly traded company on the Shanghai Stock Exchange specializing in the research, development, and manufacturing of chemical drugs, biological products, and Traditional Chinese Medicines. The company is best known for its flagship products, including Artificial Tiger Bone Powder (Jingushanghe) for bone health and Transfer Factor for immune modulation. Jinhua operates large-scale GMP-certified manufacturing facilities and maintains a significant presence in the Chinese domestic market, particularly in orthopedics and immunology. The group is recognized for its innovation in creating sustainable alternatives to traditional animal-derived medicines.